FDA Inspection 1031298 — CHRISTUS Spohn Hospital Corpus Christi-South
The FDA completed an inspection of CHRISTUS Spohn Hospital Corpus Christi-South on Oct 17, 2017 in Corpus Christi, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 17, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Corpus Christi, TX (United States)